CAMBRIDGE, Mass., May 30, 2024 Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today announced that Giuseppe Ciaramella, president.
Beam Therapeutics Reports Pipeline Updates and First globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation Application Cleared for the Phase.